78 related articles for article (PubMed ID: 17686443)
1. Survival improvement in thoracic cancer: progress from the last decade and beyond.
Manegold C; Thatcher N
Lung Cancer; 2007 Aug; 57 Suppl 2():S3-5. PubMed ID: 17686443
[TBL] [Abstract][Full Text] [Related]
2. Improving patient management in metastatic non-small cell lung cancer.
Vansteenkiste J
Lung Cancer; 2007 Aug; 57 Suppl 2():S12-7. PubMed ID: 17686440
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics in non-small-cell lung cancer chemotherapy.
Danesi R; Pasqualetti G; Giovannetti E; Crea F; Altavilla G; Del Tacca M; Rosell R
Adv Drug Deliv Rev; 2009 May; 61(5):408-17. PubMed ID: 19292993
[TBL] [Abstract][Full Text] [Related]
4. Pemetrexed for the treatment of non-small-cell lung cancer.
Manegold C; Schmid-Bindert G; Pilz LR
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
[TBL] [Abstract][Full Text] [Related]
5. [Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer].
Quoix E
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S113-8. PubMed ID: 18971835
[TBL] [Abstract][Full Text] [Related]
6. Enzastaurin, an oral serine/threonine kinase inhibitor, as second- or third-line therapy of non-small-cell lung cancer.
Oh Y; Herbst RS; Burris H; Cleverly A; Musib L; Lahn M; Bepler G
J Clin Oncol; 2008 Mar; 26(7):1135-41. PubMed ID: 18309949
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
Bunn PA; Thatcher N
Oncologist; 2008; 13 Suppl 1():1-4. PubMed ID: 18263768
[TBL] [Abstract][Full Text] [Related]
8. Pemetrexed in first-line treatment of non-small cell lung cancer.
Esteban E; Casillas M; Cassinello A
Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
[TBL] [Abstract][Full Text] [Related]
9. [Stage IV NSCLC. Biological treatments of lung cancer in 2008... and in the near future].
Bergot E; Levallet G; Zalcman G
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S119-26. PubMed ID: 18971836
[TBL] [Abstract][Full Text] [Related]
10. Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development.
Guida C; Maione P; Rossi A; Bareschino M; Schettino C; Barzaghi D; Elmo M; Gridelli C
Crit Rev Oncol Hematol; 2008 Dec; 68(3):222-32. PubMed ID: 18632283
[TBL] [Abstract][Full Text] [Related]
11. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion.
Bunn PA; Thatcher N
Oncologist; 2008; 13 Suppl 1():37-46. PubMed ID: 18263773
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of novel treatment strategies.
Giaccone G
Oncogene; 2002 Oct; 21(45):6970-81. PubMed ID: 12362278
[TBL] [Abstract][Full Text] [Related]
13. Individualized therapy in non-small-cell lung cancer: future versus current clinical practice.
Pérez-Soler R
Oncogene; 2009 Aug; 28 Suppl 1():S38-45. PubMed ID: 19680295
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategy for treatment of metastatic non-small cell lung cancer.
Berhoune M; Banu E; Scotte F; Prognon P; Oudard S; Bonan B
Ann Pharmacother; 2008 Nov; 42(11):1640-52. PubMed ID: 18957625
[TBL] [Abstract][Full Text] [Related]
15. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
Crawford J
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
[TBL] [Abstract][Full Text] [Related]
16. Potential treatment options after first-line chemotherapy for advanced NSCLC: maintenance treatment or early second-line?
Gridelli C; Maione P; Rossi A; Ferrara ML; Bareschino MA; Schettino C; Sacco PC; Ciardiello F
Oncologist; 2009 Feb; 14(2):137-47. PubMed ID: 19190239
[TBL] [Abstract][Full Text] [Related]
17. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer.
Zhang Z; Xu F; Wang S; Li N; Wang C
Lung Cancer; 2008 Jun; 60(3):434-40. PubMed ID: 18036699
[TBL] [Abstract][Full Text] [Related]
18. Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.
Bearz A; Garassino I; Cavina R; Favaretto A; Boccalon M; Talamini R; Berretta M; Spazzapan S; Simonelli C; Santoro A; Tirelli U
Lung Cancer; 2008 May; 60(2):240-5. PubMed ID: 18022729
[TBL] [Abstract][Full Text] [Related]
19. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC
Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457
[TBL] [Abstract][Full Text] [Related]
20. Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs.
Burris HA
Oncogene; 2009 Aug; 28 Suppl 1():S4-13. PubMed ID: 19680296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
